Michael Albert Alrutz - 01 Feb 2024 Form 4 Insider Report for CHIMERIX INC

Role
SVP AND GENERAL COUNSEL
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
4
Filing time
02 Feb 2024, 18:30:06 UTC
Previous filing
19 Jan 2023
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +21,875 +15% $0.000000 168,098 01 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +131,250 $0.000000 131,250 01 Feb 2024 Common Stock 131,250 $0.9300 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 5,468 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 5,471 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes 1,809 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2023 and 2,399 shares acquired under the ESPP on September 8, 2023.
F3 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.